Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

August 26, 2019

Study Completion Date

August 26, 2019

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG

Pegcetacoplan

Complement (C3) Inhibitor

Trial Locations (7)

Waikato Hospital, Hamilton

Ramathibodi Hospital, Bangkok

Siriraj hospital, Bangkok

Hospital Ampang, Ampang

Prince of Wales Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Phramongkutklao Hospital, Bangkok